0001209191-22-053212.txt : 20221011 0001209191-22-053212.hdr.sgml : 20221011 20221011090017 ACCESSION NUMBER: 0001209191-22-053212 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221007 FILED AS OF DATE: 20221011 DATE AS OF CHANGE: 20221011 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brumm Joshua T CENTRAL INDEX KEY: 0001528826 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39509 FILM NUMBER: 221302528 MAIL ADDRESS: STREET 1: ZELTIQ AESTHETICS INC. STREET 2: 4698 WILLOW ROAD SUITE 100 CITY: PLEASANTON STATE: CA ZIP: 94588 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dyne Therapeutics, Inc. CENTRAL INDEX KEY: 0001818794 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 364883909 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1560 TRAPELO ROAD CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 786-8230 MAIL ADDRESS: STREET 1: 1560 TRAPELO ROAD CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-10-07 0 0001818794 Dyne Therapeutics, Inc. DYN 0001528826 Brumm Joshua T C/O DYNE THERAPEUTICS, INC. 1560 TRAPELO ROAD WALTHAM MA 02451 1 1 0 0 See Remarks Common Stock 2022-10-07 4 M 0 14200 1.03 A 218823 D Common Stock 2022-10-07 4 S 0 14200 13.37 D 204623 D Common Stock 2022-10-10 4 M 0 195800 1.03 A 400423 D Common Stock 2022-10-10 4 S 0 195800 12.46 D 204623 D Common Stock 2022-10-10 5 G 0 E 13000 0.00 D 191623 D Common Stock 2022-10-10 5 G 0 E 2500 0.00 D 189123 D Stock Option (right to buy) 1.03 2022-10-07 4 M 0 14200 0.00 D 2030-01-05 Common Stock 14200 543549 D Stock Option (right to buy) 1.03 2022-10-10 4 M 0 195800 0.00 D 2030-01-05 Common Stock 195800 347749 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $12.70 to $13.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) of this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $12.30 to $12.91, inclusive. This transaction was a charitable donation to a third party effective October 10, 2022 in which no value was received in return. The option was granted on January 6, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on October 12, 2020 and the remaining shares vesting in equal quarterly installments thereafter. Chief Executive Officer and President /s/ Richard Scalzo, Attorney-in-Fact 2022-10-11